Skip to main content
. 2022 Sep 8;33(2):959–969. doi: 10.1007/s00330-022-09113-7

Table 1.

Clinical information related to the 141 breast scans involved in the study. Quantitative features are given by mean values ± standard deviation; qualitative features are given by the number of cases (percentage)

Age of patients 48 ± 11 (years)
Largest diameter of tumor 29 ± 13 (mm)
Primary tumor: T stage
I/II/III/IV 34 (24%)/83 (59%)/19 (13%)/5 (4%)
Regional lymph node: N stage
0/I/II 77 (55%)/62 (44%)/2 (1%)
Distant metastasis: M stage
0/I 139 (99%)/2 (1%)
Tumor type
Ductal NOS/Others 137 (97%)/4 (3%)
Breast cancer subtype
Luminal/HER2+/TN 41 (29%)/37 (26%)/63 (45%)

NOS not otherwise specified, HER2+ human epidermal growth factor receptor 2 positive, TN triple negative